+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
WELCURE WELCURE

Welcure Drugs & Pharmaceuticals Share Price

 
77.97% Fall from 52W High

 

Welcure Drugs & Pharmaceuticals live price: ₹0.26.

Welcure Drugs & Pharmaceuticals Performance

  • Today's Low
  • ₹0
  • Today's High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹1
  • Open Price₹0
  • Previous Close₹0
  • Volume1,466,402
  • 50 DMA₹0.30
  • 100 DMA₹0.30
  • 200 DMA₹0.40

Welcure Drugs & Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -7.14%
  • Over 3 Month -16.13%
  • Over 6 Month -29.73%
  • Over 1 Year -74%

Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!

Invest Now

Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.9
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 32
  • P/B Ratio
  • 0.3
  • Average True Range
  • 0.02
  • EPS
  • -0.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 50.02
  • MFI
  • 64.36

Latest Stock News Updates

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Ltd Held On Today I.E. Tuesday, 14Th July, 2026.

Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd held on today i.e. Tuesday, 14th July, 2026.

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Resignation of Company Secretary and Compliance Officer

Welcure Drugs & Pharmaceuticals Ltd - 524661 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs & Pharmaceuticals Limited Held On Today I.E. Friday, 19Th June, 2026

Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Friday, 19th June, 2026

Welcure Drugs & Pharmaceuticals Financials

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹0.26
+ 0.01 (4%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹0.30
  • 50 Day
  • ₹0.30
  • 100 Day
  • ₹0.30
  • 200 Day
  • ₹0.40

Resistance and Support

0.25 Pivot Speed
  • R3 0.30
  • R2 0.30
  • R1 0.30
  • S1 0.30
  • S2 0.20
  • S3 0.20

Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-02-12 Quarterly Results
2025-12-05 Right Issue of Equity Shares
2025-11-27 To consider raisinf of funds Inter-alia, 1. To augment the financial resources of the Company via funds raising by way of issue of equity shares/convertible instruments/other securities through permissable modes.
2025-11-13 Quarterly Results
Date Purpose Remarks
2025-10-16 Split Stock split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2025-10-16 Bonus Bonus issue of equity shares in the ratio of 1:10 of Re. 1/-.

Welcure Drugs & Pharmaceuticals Shareholding Pattern

100%
0%
0%

About Welcure Drugs & Pharmaceuticals

Welcure Drugs & Pharmaceuticals manufactures and trades pharmaceutical drugs. The Company manufactures a wide range of drugs in formulations that include tablets, capsules, liquid orals, and dry syrups. View More
  • NSE Symbol
  • WELCURE
  • BSE Symbol
  • 524661
  • ISIN
  • INE331C01025

Similar Stocks to Welcure Drugs & Pharmaceuticals

Welcure Drugs & Pharmaceuticals FAQs

Welcure Drugs & Pharmaceuticals share price is ₹0 As on 21 July, 2026 | 22:34

The Market Cap of Welcure Drugs & Pharmaceuticals is ₹32.1 Cr As on 21 July, 2026 | 22:34

The P/E ratio of Welcure Drugs & Pharmaceuticals is -1.9 As on 21 July, 2026 | 22:34

The PB ratio of Welcure Drugs & Pharmaceuticals is 0.3 As on 21 July, 2026 | 22:34

The 52 week High & Low of Welcure Drugs & Pharmaceuticals is ₹1.2/₹0.2 respectively As on 21 July, 2026 | 22:34

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23